MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/alz.70465

Медицинская библиотека · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

Association and interaction of blood homocysteine and p-tau217 levels with temporal cortical thinning and cognitive impairment in Alzheimer's disease.

Wang Qiang, Zhong Xiaomei, Gao Pengbo, Xiao Zhidai, Chen Ben, Tan Haoye, Liu Qin, Yao Kexin, Liang Shuang, Li JiaFu, Yang Mingfeng, Xu Danyan, Lin Gaohong, Wu Zhangying, Shi Haishan, Zhang Min, Shi Xiaolei, Liu Huanmin, Zeng Yijie, Chen Yunheng, Lin Yicheng, Zhang Shuwei, Ouyang Cong, Tian Shihan, Gan Yujing, Zeng Mingyong, Lv Jieqin, Liang Xiang, Cheng Yuwang, Guo Jianwen, Ran Pengcheng, Ning Yuping, Zhou Huarong

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

The relationships between blood homocysteine (Hcy), amyloid beta (Aβ), tau pathology, and their combined effects on cortical thinning and cognitive impairment in Alzheimer's disease (AD) remain poorly understood.

METHODS

Participants were stratified into Aβ+ and Aβ- groups by positron emission tomography. Blood levels of Hcy, AD biomarkers (phosphorylated tau-217 [p-tau217], p-tau181, and Aβ), cortical thickness (via magnetic resonance imaging), and cognitive performance were assessed.

RESULTS

Aβ+ individuals exhibited increased blood Hcy and p-tau217 levels, which negatively correlated with temporal cortical thickness and cognitive function. A significant interaction between Hcy and p-tau217 was observed in Aβ+ participants, with high Hcy exacerbating the detrimental effects of p-tau217 on temporal cortical thinning and cognitive deficits. In Aβ- individuals, Hcy levels were independently associated with tau pathology.

DISCUSSION: Increased Hcy and p-tau217 levels synergistically contribute to cortical thinning and cognitive impairment, highlighting that Hcy may be a modifiable risk factor for AD progression. Highlights Increased blood levels of homocysteine (Hcy) and phosphorylated tau-217 (p-tau217) are independently and interactively associated with temporal cortical thinning and cognitive deficits. Hcy may predominantly affect tau pathology compared to amyloid aggregation, with its impact on neurodegeneration depending on coexisting pathologies. Hcy may serve as a supplementary indicator rather than as an independent predictor in Alzheimer's disease. Hcy may serve as a modifiable risk factor, whereas p-tau217 as a superior diagnostic biomarker and potential therapeutic target.

Для цитирования: Wang Qiang, Zhong Xiaomei, Gao Pengbo, Xiao Zhidai, Chen Ben, Tan Haoye, Liu Qin, Yao Kexin, Liang Shuang, Li JiaFu, Yang Mingfeng, Xu Danyan, Lin Gaohong, Wu Zhangying, Shi Haishan, Zhang Min, Shi Xiaolei, Liu Huanmin, Zeng Yijie, Chen Yunheng, Lin Yicheng, Zhang Shuwei, Ouyang Cong, Tian Shihan, Gan Yujing, Zeng Mingyong, Lv Jieqin, Liang Xiang, Cheng Yuwang, Guo Jianwen, Ran Pengcheng, Ning Yuping, Zhou Huarong. Association and interaction of blood homocysteine and p-tau217 levels with temporal cortical thinning and cognitive impairment in Alzheimer's disease.. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025. DOI: 10.1002/alz.70465.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.